Conquering Diseases

Investigational Study for Young Patients with Newly Diagnosed B Acute Lymphoblastic Leukemia

Description

Seeking males & females 1-31 years of age who have completed induction therapy for B Lymphoblastic Leukemia (B-ALL) & it has has been classified as a very high risk B-ALL (VHR B-ALL).

Overview

The overall goals are to are to determine end of Consolidation disease status and better understand the effects of cancer treatment in people with VHR B-ALL.

What we're hoping for

We are hoping that an assessment of Minimal Residual Disease Evaluation (MRD), which may help determine the treatment options following Consolidation therapy.

Additional Information

ClinicalTrials.gov Identifier: NCT02883049

 Principal Investigator

Christopher  Keuker, MD

UMass Memorial Health Care

 Study Contact

Pediatrics Hem-Oncology  Research Center

774-441-8083

pedihemonc@umassmemorial.org

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989